Biomaterial Database

Changes in antithrombin 3 levels following cessation of anticoagulant therapy. 1973

O Refvem, and M K Fagerhol, and U Abildgaard

UI	MeSH Term	Description	Entries
D008259	Macroglobulins	Serum globulins with high molecular weight. (Dorland, 28th ed)
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D001778	Blood Coagulation Disorders	Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.	Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001780	Blood Coagulation Tests	Laboratory tests for evaluating the individual's clotting mechanism.	Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D003327	Coronary Disease	An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.	Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003864	Depression, Chemical	The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.	Chemical Depression,Chemical Depressions,Depressions, Chemical
D005260	Female		Females
D005340	Fibrinogen	Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.	Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005779	Immunodiffusion	Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.	Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion

Related Publications

O Refvem, and M K Fagerhol, and U Abildgaard

Effect of anticoagulant therapy on antithrombin III levels.

August 1982, Journal of the American Medical Women's Association (1972),

O Refvem, and M K Fagerhol, and U Abildgaard

The reduced anticoagulant effect of fondaparinux at low antithrombin levels.

September 2009, Anesthesia and analgesia,

O Refvem, and M K Fagerhol, and U Abildgaard

Effect of long-term anticoagulant therapy on antithrombin activity.

January 1965, Therapia Hungarica (English edition),

O Refvem, and M K Fagerhol, and U Abildgaard

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.

January 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,

O Refvem, and M K Fagerhol, and U Abildgaard

[Antithrombin III control in patients with long-term anticoagulant therapy].

January 1991, Deutsche Zeitschrift fur Mund-, Kiefer- und Gesichts-Chirurgie,

O Refvem, and M K Fagerhol, and U Abildgaard

Recurrent myocardial infarction after cessation of anticoagulant therapy.

July 1960, American heart journal,

O Refvem, and M K Fagerhol, and U Abildgaard

Anticoagulant treatment during abdominal surgery in a case of antithrombin 3 deficiency.

January 1973, Acta chirurgica Scandinavica,

O Refvem, and M K Fagerhol, and U Abildgaard

[Antithrombin III changes following myocardial infarct].

September 1984, Klinische Wochenschrift,